From Pre to Post Bariatric Surgery: 2020 Canadian Adult Obesity Clinical Practice Guidelines
Since the last Canadian Obesity Guidelines were published in 2006, there is now so much new...
Read More
Category: Diabetes
Medications For Weight Management: Canadian Obesity Guidelines
Successful weight management is challenging for most people, as human biology is engineered by...
Read More
Once Weekly Insulin For Treatment of Diabetes?
In our efforts to make it easier for people to manage their diabetes, there is a movement towards...
Read More
New Diabetes Guidelines On Pharmacotherapy Published!
Hot off the presses this week are the much anticipated Diabetes Canada Guidelines on medications...
Read More
The DAPA-CKD Trial: What Does It Mean for Primary Care?
In follow up to my recent blog post sharing the breaking news of the DAPA-CKD trial, below is a...
Read More
Breaking News: SGLT2 Inhibitors Show Kidney Protection and Heart Failure benefits in people with or without diabetes
While the class of medications called SGLT2 inhibitors were originally developed as treatments for...
Read More
Could Metformin Improve COVID-19 Survival?
Metformin is a medication that is the first line of treatment for type 2 diabetes. It is also...
Read More
Semaglutide As The Next Obesity Medication?
Semaglutide is an analog of the human hormone GLP-1, which is a hormone that our intestines...
Read More
Can COVID-19 Cause Diabetes?
As blogged previously, we know that people with diabetes have a higher risk of more severe...
Read More
Type 1 vs Type 2 Diabetes and Risk Of Severe COVID-19 Infection
We know that people with diabetes are at not at a higher risk of getting a COVID-19 infection, but...
Read More
Diabetes During COVID-19 and Beyond: Time In Range
Having good control of blood sugars is important to prevent complications of diabetes. We also...
Read More
UPDATE: Cardiovascular Medications – ACE Inhibitors, ARBs, and COVID-19
As blogged previously, the question has been raised as to whether use of angiotensin converting...
Read More
Dr. Sue Pedersen
I am a medical doctor, Specialist in Endocrinology & Metabolism, and a Diplomate of the American Board of Obesity Medicine. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. I am also involved in clinical research in diabetes and obesity. I am a member of the Expert Committee for the 2018 Diabetes Canada Guidelines, and an author on the upcoming Canadian Obesity Guidelines. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity, diabetes, and healthy living; and to help us become a healthier society!
Pageviews since 2008
Thank you for visiting my website.
